Page last updated: 2024-09-03

pramipexole and Allodynia

pramipexole has been researched along with Allodynia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Avegno, EM; Barattini, AE; Callicoatte, CN; Cucinello-Ragland, JA; Edwards, KN; Edwards, S; Gilpin, NW; Melain, A; Pahng, AR1
Godínez-Chaparro, B; Mendoza-Pérez, F; Pérez-Ramos, J; Santamaria-Anzures, J1
Escalona, PR; Haynes, MK; Milligan, ED; Noor, S; Pasmay, A; Sanchez, JE; Sanchez, JJ; Sklar, LA; Sun, MS; Vanderwall, AG; Zimmerly, J1
Austrich-Olivares, AM; Benitez-Diaz Mirón, M; Coen, A; Garza-Mouriño, G; Godínez-Chaparro, B; Mendieta, L; Romero-Sánchez, HA1

Other Studies

4 other study(ies) available for pramipexole and Allodynia

ArticleYear
Pramipexole treatment attenuates mechanical hypersensitivity in male rats experiencing chronic inflammatory pain.
    Neuropharmacology, 2022, 05-01, Volume: 208

    Topics: Analgesics, Opioid; Animals; Chronic Pain; Dopamine; Hyperalgesia; Levodopa; Male; Pramipexole; Rats; Rats, Long-Evans

2022
Pramipexole inhibits formalin-induce acute and long-lasting mechanical hypersensitivity via NF-kB pathway in rats.
    Drug development research, 2023, Volume: 84, Issue:2

    Topics: Animals; Formaldehyde; Hyperalgesia; NF-kappa B; Pain; Pramipexole; Quality of Life; Rats; Rats, Wistar

2023
The FDA-approved compound, pramipexole and the clinical-stage investigational drug, dexpramipexole, reverse chronic allodynia from sciatic nerve damage in mice, and alter IL-1β and IL-10 expression from immune cell culture.
    Neuroscience letters, 2023, 09-25, Volume: 814

    Topics: Animals; Cell Culture Techniques; Cytokines; Drugs, Investigational; Humans; Hyperalgesia; Interleukin-10; Mice; Neuralgia; Peripheral Nerve Injuries; Pramipexole; Rats; Sciatic Nerve; Sciatic Neuropathy; Spinal Cord

2023
Unilateral lesion of the nigroestriatal pathway with 6-OHDA induced allodynia and hyperalgesia reverted by pramipexol in rats.
    European journal of pharmacology, 2020, Feb-15, Volume: 869

    Topics: Analgesics; Animals; Antiparkinson Agents; Dopamine Agonists; Hyperalgesia; Male; Oxidopamine; Pars Compacta; Pramipexole; Rats, Wistar; Touch

2020